Researchers Press WHO to Reconsider Costly Drugs for Essential Medicines List

The World Health Organization (WHO) should include drugs on its essential medicines list regardless of their cost, according to a group of researchers that advocates separating reviews of comparative effectiveness, safety and public health priority from consideration of the price of medicines and their cost-effectiveness.
Source: Drug Industry Daily